Contents
Current Medicinal Chemistry, Volume 20 - Number 3
Editorial (Hot Topic: Molecular Bases of Antipsychotic Drugs: The Contribution of Neurosciences)
, 20(3): 311Stefan Borgwardt and Andre Schmidt
DOI: 10.2174/0929867311320030001
A Genetic Dissection of Antipsychotic Induced Movement Disorders
, 20(3): 312 - 330C. Crisafulli, A. Drago, A. Sidoti and A. Serretti
DOI: 10.2174/0929867311320030002
Neurotransmitters, Psychotropic Drugs and Microglia: Clinical Implications for Psychiatry
, 20(3): 331 - 344T. A. Kato, Y. Yamauchi, H. Horikawa, A. Monji, Y. Mizoguchi, Y. Seki, K. Hayakawa, H. Utsumi and S. Kanba
DOI: 10.2174/0929867311320030003
Recent Developments in Neurochemical Imaging in Schizophrenia: An Update
, 20(3): 351 - 356Nora S. Vyas, Neva H. Patel, Peter Herscovitch, Basant K. Puri and Rupert Lanzenberger
DOI: 10.2174/0929867311320030005
Facilitative Effect of Serotonin1A Receptor Agonists on Cognition in Patients with Schizophrenia
, 20(3): 357 - 362T. Sumiyoshi and Y. Higuchi
DOI: 10.2174/0929867311320030006
The Role of GABA-A Receptor in the Synergism Between SSRI and Antipsychotic in Schizophrenia; Implications for Antipsychotic Modes of Actions
, 20(3): 363 - 370Henry Silver, Reef Einoch, Moussa Youdim and Orly Weinreb
DOI: 10.2174/0929867311320030007
Serotonin Receptors of Type 6 (5-HT6): From Neuroscience to Clinical Pharmacology
, 20(3): 371 - 377Donatella Marazziti, Stefano Baroni, Franco Borsini, Michela Picchetti, Elena Vatteroni, Valentina Falaschi and Mario Catena-Dell’Osso
DOI: 10.2174/0929867311320030008
Neurobiological Basis of Dyskinetic Effects Induced by Antipsychotics: the Contribution of Animal Models
, 20(3): 389 - 396Meaghan C. Creed and Jose N. Nobrega
DOI: 10.2174/0929867311320030010
Abnormal Striatal Dopamine Transmission in Schizophrenia
, 20(3): 397 - 404Jerome Brunelin, Shirley Fecteau and Marie-Francoise Suaud-Chagny
DOI: 10.2174/0929867311320030011
Transcranial Brain Stimulation in Schizophrenia: Targeting Cortical Excitability, Connectivity and Plasticity
, 20(3): 405 - 413A. Hasan, P. Falkai and T. Wobrock
DOI: 10.2174/0929867311320030012
Proton Magnetic Resonance Spectroscopy Changes After Antipsychotic Treatment
, 20(3): 414 - 427Agata Szulc, Beata Galinska-Skok, Napoleon Waszkiewicz, Daniel Bibulowicz, Beata Konarzewska and Eugeniusz Tarasow
DOI: 10.2174/0929867311320030013
Antipsychotic Drug Effects in Schizophrenia: A Review of Longitudinal fMRI Investigations and Neural Interpretations
, 20(3): 428 - 437C. C. Abbott, A. Jaramillo, C. E. Wilcox and D. A. Hamilton
DOI: 10.2174/0929867311320030014
Volumetric Changes in the Basal Ganglia After Antipsychotic Monotherapy: A Systematic Review
, 20(3): 438 - 447B. H. Ebdrup, H. Norbak, S. Borgwardt and B. Glenthoj
DOI: 10.2174/0929867311320030015
Systematic Review of the Influence of Antipsychotics on the Blood Oxygenation Level-Dependent Signal of Functional Magnetic Resonance Imaging
, 20(3): 448 - 461C. H. Roder, S. Dieleman, F. M. van der Veen and D. Linden
DOI: 10.2174/0929867311320030016
A General Approach for Combining Voxel-Based Meta-Analyses Conducted in Different Neuroimaging Modalities
, 20(3): 462 - 466J. Radua, M. Romeo, D. Mataix-Cols and P. Fusar-Poli
DOI: 10.2174/0929867311320030017
Do Subjects at Clinical High Risk for Psychosis Differ from those with a Genetic High Risk? - A Systematic Review of Structural and Functional Brain Abnormalities
, 20(3): 467 - 481R. Smieskova, J. Marmy, A. Schmidt, K. Bendfeldt, A. Riecher-Rossler, M. Walter, U. E. Lang and S. Borgwardt
DOI: 10.2174/0929867311320030018
Webmaster Contact: info@benthamscience.org